about
Public Health Aspects of Migrant Health: A Review of the Evidence on Health Status for Labour Migrants in the European RegionHealth system performance assessment landscape at the EU level: a structured synthesis of actors and actions.Multiple imputation to deal with missing EQ-5D-3L data: Should we impute individual domains or the actual index?A randomised controlled trial of positive memory training for the treatment of depression within schizophrenia.Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.EQ-5D studies in musculoskeletal and connective tissue diseases in eight Central and Eastern European countries: a systematic literature review and meta-analysis.Costing evidence for health care decision-making in Austria: A systematic review.Remote mood monitoring for adults with bipolar disorder: An explorative study of compliance and impact on mental health service use and costs.EQ-5D in Central and Eastern Europe: 2000-2015.Health-Related Resource-Use Measurement Instruments for Intersectoral Costs and Benefits in the Education and Criminal Justice SectorsThe effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial.Psychometric validation of a multi-dimensional capability instrument for outcome measurement in mental health research (OxCAP-MH).Psychoeducation and online mood tracking for patients with bipolar disorder: A randomised controlled trial.Prevalence of mental diseases in Austria : Systematic review of the published evidence.Health literacy, pain intensity and pain perception in patients with chronic pain.Community treatment orders and social outcomes for patients with psychosis: a 48-month follow-up study.Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.EQ-5D studies in cardiovascular diseases in eight Central and Eastern European countries: a systematic review of the literature.Operationalising the capability approach for outcome measurement in mental health research.Cultural and linguistic transferability of the multi-dimensional OxCAP-MH capability instrument for outcome measurement in mental health: the German language version.Headline indicators for monitoring the performance of health systems: findings from the european Health Systems_Indicator (euHS_I) survey.Comparative economic evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in patients with bipolar depression (CEQUEL)Comparison of statistical analysis methods for object case best–worst scalingAdvancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14–16, 2018; Vienna, AustriaThe societal costs of chronic pain and its determinants: The case of AustriaValue of monitoring negative emotional bias in primary care in England for personalised antidepressant treatment: a modelling studyMonitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015Measuring broader wellbeing in mental health services: validity of the German language OxCAP-MH capability instrumentEQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature reviewCost-of-illness studies in nine Central and Eastern European countriesThe excess economic burden of mental disorders: findings from a cross-sectional prevalence survey in Austria
P50
Q28077328-3C734FAF-240B-4487-9D76-2FAFBEC26499Q30379070-6F35495D-8910-4C00-9145-41448CBFEFF8Q30874146-2E5F155D-B19E-48B0-8C1E-AE55E1D75AA0Q35552263-5834DE7B-A3FA-4C23-B2F4-5AD5E7E9D329Q35994075-A8F72965-2427-4080-AF1A-E9D05CF8FEB4Q38636348-183692E8-B5CE-4810-AFF4-FCF5117EE870Q38642791-91E4ECA3-24E1-410F-A07E-9D7E36CD3EFDQ38669833-EA4B8C15-8ECA-4326-8551-2D4794EA770AQ38912637-E708B4BA-DC54-47C5-9853-4D5A2F0F975EQ39361444-CAFCE4D7-354D-4533-87BF-19093FFFDD2AQ47130954-0A93CDB1-A333-4316-BEB0-46DA55EC2374Q47163737-F9E3B342-02F6-4EE7-A82C-C335E3B9ACDBQ47407185-9989D4B9-2CBA-4B1B-845C-73D480A833DAQ47552125-400A877D-D242-4238-AC6A-A5C298670FCCQ47561520-846520DA-AC80-4A95-AEB3-08969093C94EQ47623435-FC964B54-04B3-49F2-83EB-3CA4EABD1412Q47631763-52F7DBEA-6592-4F69-A917-0CBB6AC06294Q48068105-22160741-9A11-42BC-9DDC-2F8C2DA1F628Q48513894-6CD50446-66FC-4386-AD63-C8E43C771951Q50671878-4B11F197-7BA9-49C6-A6E3-3BF4611AE7F8Q55491825-3E9AAE45-0509-4DB1-A295-6ECC85D993A5Q55514227-5D3E96C8-0889-48E1-AEC3-765DB114F79FQ58093267-57FD3B56-1375-4317-BD92-E537E08F7658Q60624393-513F796C-5912-4081-886B-618A782E497BQ63610247-41495840-72AE-4514-9282-894B5B677CD1Q64072402-C4D5F96F-9A22-4AC5-9823-D792ADB00CD2Q90338453-5C28358E-7D2F-4AF9-9B70-53F0BB848CBEQ91422198-6F4E72A2-9E12-4104-B920-F51BBA7A67B3Q91572374-C2FD5CC2-2A0C-4141-B5C1-61780104AB66Q92102042-32DF4A94-CCC1-4221-8263-E52E9D2E013DQ92139201-2F32844D-DA6C-4DBF-82AA-B3B1AD8DD3C0Q95843192-0CBAF150-B961-402C-A500-22D346AFA949
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Judit Simon
@en
Judit Simon
@es
Judit Simon
@fr
Judit Simon
@nl
Judit Simon
@sl
Simon Judit
@hu
type
label
Judit Simon
@en
Judit Simon
@es
Judit Simon
@fr
Judit Simon
@nl
Judit Simon
@sl
Simon Judit
@hu
prefLabel
Judit Simon
@en
Judit Simon
@es
Judit Simon
@fr
Judit Simon
@nl
Judit Simon
@sl
Simon Judit
@hu
P214
P106
P21
P214
P31
P3835
judit-simon
P496
0000-0001-9279-8627
P734
P735
P7859
viaf-89951028